Literature DB >> 26769969

Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43.

Takashi Nonaka1, Genjiro Suzuki2, Yoshinori Tanaka2, Fuyuki Kametani2, Shinobu Hirai3, Haruo Okado3, Tomoyuki Miyashita4, Minoru Saitoe4, Haruhiko Akiyama2, Hisao Masai5, Masato Hasegawa2.   

Abstract

Intracellular aggregates of phosphorylated TDP-43 are a major component of ubiquitin-positive inclusions in the brains of patients with frontotemporal lobar degeneration and ALS and are considered a pathological hallmark. Here, to gain insight into the mechanism of intracellular TDP-43 accumulation, we examined the relationship between phosphorylation and aggregation of TDP-43. We found that expression of a hyperactive form of casein kinase 1 δ (CK1δ1-317, a C-terminally truncated form) promotes mislocalization and cytoplasmic accumulation of phosphorylated TDP-43 (ubiquitin- and p62-positive) in cultured neuroblastoma SH-SY5Y cells. Insoluble phosphorylated TDP-43 prepared from cells co-expressing TDP-43 and CK1δ1-317 functioned as seeds for TDP-43 aggregation in cultured cells, indicating that CK1δ1-317-induced aggregated TDP-43 has prion-like properties. A striking toxicity and alterations of TDP-43 were also observed in yeast expressing TDP-43 and CK1δ1-317. Therefore, abnormal activation of CK1δ causes phosphorylation of TDP-43, leading to the formation of cytoplasmic TDP-43 aggregates, which, in turn, may trigger neurodegeneration.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ALS (Lou Gehrig disease); TAR DNA-binding protein of 43 kDa (TDP-43); casein kinase 1δ; frontotemporal lobar degeneration (FTLD); phosphorylation; protein aggregation; protein kinase

Mesh:

Substances:

Year:  2016        PMID: 26769969      PMCID: PMC4786690          DOI: 10.1074/jbc.M115.695379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Front Biosci       Date:  2008-01-01

2.  TDP-43: an emerging new player in neurodegenerative diseases.

Authors:  I-Fan Wang; Lien-Szu Wu; C-K James Shen
Journal:  Trends Mol Med       Date:  2008-10-15       Impact factor: 11.951

3.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Authors:  Yong-Jie Zhang; Ya-Fei Xu; Casey Cook; Tania F Gendron; Paul Roettges; Christopher D Link; Wen-Lang Lin; Jimei Tong; Monica Castanedes-Casey; Peter Ash; Jennifer Gass; Vijayaraghavan Rangachari; Emanuele Buratti; Francisco Baralle; Todd E Golde; Dennis W Dickson; Leonard Petrucelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

4.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

5.  Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.

Authors:  Takashi Nonaka; Tetsuaki Arai; Emanuele Buratti; Francisco E Baralle; Haruhiko Akiyama; Masato Hasegawa
Journal:  FEBS Lett       Date:  2008-12-25       Impact factor: 4.124

6.  Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.

Authors:  Matthew J Winton; Lionel M Igaz; Margaret M Wong; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

7.  Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS.

Authors:  Yuki Inukai; Takashi Nonaka; Tetsuaki Arai; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco E Baralle; Haruhiko Akiyama; Shin-ichi Hisanaga; Masato Hasegawa
Journal:  FEBS Lett       Date:  2008-07-24       Impact factor: 4.124

8.  Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.

Authors:  Lionel M Igaz; Linda K Kwong; Alice Chen-Plotkin; Matthew J Winton; Travis L Unger; Yan Xu; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

9.  Structural determinants of the cellular localization and shuttling of TDP-43.

Authors:  Youhna M Ayala; Paola Zago; Andrea D'Ambrogio; Ya-Fei Xu; Leonard Petrucelli; Emanuele Buratti; Francisco E Baralle
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

Review 10.  NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.

Authors:  Michel Goedert
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

View more
  39 in total

1.  Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors.

Authors:  Eleonora Cescon; Giovanni Bolcato; Stephanie Federico; Maicol Bissaro; Alice Valentini; Maria Grazia Ferlin; Gianpiero Spalluto; Mattia Sturlese; Stefano Moro
Journal:  ACS Med Chem Lett       Date:  2020-04-28       Impact factor: 4.345

Review 2.  Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics.

Authors:  Mario Hofweber; Dorothee Dormann
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

3.  Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.

Authors:  Laurent Coudert; Takashi Nonaka; Emilien Bernard; Masato Hasegawa; Laurent Schaeffer; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2019-03-12       Impact factor: 9.261

Review 4.  Regulation of Cellular Ribonucleoprotein Granules: From Assembly to Degradation via Post-translational Modification.

Authors:  Pureum Jeon; Hyun-Ji Ham; Semin Park; Jin-A Lee
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

Review 5.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

Review 6.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

7.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.

Authors:  Alexander E Conicella; Gül H Zerze; Jeetain Mittal; Nicolas L Fawzi
Journal:  Structure       Date:  2016-08-18       Impact factor: 5.006

Review 8.  RNA transport and local translation in neurodevelopmental and neurodegenerative disease.

Authors:  Michael S Fernandopulle; Jennifer Lippincott-Schwartz; Michael E Ward
Journal:  Nat Neurosci       Date:  2021-01-28       Impact factor: 24.884

Review 9.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 10.  Stress Granules and Neurodegenerative Disorders: A Scoping Review.

Authors:  Mohammad Reza Asadi; Marziyeh Sadat Moslehian; Hani Sabaie; Abbas Jalaiei; Soudeh Ghafouri-Fard; Mohammad Taheri; Maryam Rezazadeh
Journal:  Front Aging Neurosci       Date:  2021-06-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.